Human CYP1A1 allelic variants:: baculovirus expression and purification, hydrodynamic, spectral, and catalytical properties and their potency in the formation of all-trans-retinoic acid

被引:18
作者
Chernogolov, A
Behlke, J
Schunck, WH
Roots, I
Schwar, D
机构
[1] Humboldt Univ, Univ Med Ctr Charite, Inst Clin Pharmacol, D-10098 Berlin, Germany
[2] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
关键词
D O I
10.1016/S1046-5928(02)00672-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Three human cytochrome P450 1A1 (CYP1A1) allelic variants, namely wild-type (CYP1A1.1), CYP1A1.2 (I462V), and CY-P1A1.4 (T461N), we re expressed as C-terminal His-tagged fusions including a thrombin cleavage site in Spodoptera frugiperda insect cells by baculovirus infection. The variants were expressed with 30-90 nmol (1.8-5.4 mg) spectrally active cytochrome MO per one liter of culture and purified to electrophoretic homogeneity by Ni-agarose chromatography. The recombinant variants were structurally characterized by UV/Vis, ultracentrifugation, and EPR. Optical and EPR spectra showed all three variants predominantly in high spin state; moreover, EPR indicated changes in the electronic structure of the heme iron of the two mutant variants. Sedimentation equilibrium experiments demonstrated the purified variants in dimeric state in the presence of 0.2% emulgen+0.05% cholate. Higher detergent concentration, the presence of imidazole, and cleavage of the His-tag led to monomerization. Catalytic activity of all purified variants was reconstituted with purified human NADPH-P450 reductase and dilaurylphosphatidylcholine. Enzyme kinetics of ethoxyresorufin O-deethylation revealed similar K-m (approximate to 0.4 muM) for all variants but slightly different V-max values (CYP1A1.1: 4.2, CYP1A1.2: 7.0, and CYP1A1.4: 3.0 nmol/min/nmol CYP1A1). The extended C-terminus influenced the enzymatic activity only slightly. All three variants are able to produce significant amounts of all-trans-retinoic acid from all-trans-retinal with V-max of 4.0, 3.3, and 5.6 nmol/min/nmol CYP1A1 and K-m values of 111, 83, and 250 muM for CYP1A1.1, CYP1A1.2, and CYP1A1.4, respectively. Availability of the three purified human CYP1A1 variants should facilitate further characterization of their role in metabolism of endogenous and exogenous compounds as well as structural studies. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:259 / 269
页数:11
相关论文
共 30 条
[1]   Nucleotide-dependent complex formation between the Escherichia coli chaperonins GroEL and GroES studied under equilibrium conditions [J].
Behlke, J ;
Ristau, O ;
Schonfeld, HJ .
BIOCHEMISTRY, 1997, 36 (17) :5149-5156
[2]  
BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
[3]  
BUTERS JTM, 1995, DRUG METAB DISPOS, V23, P696
[4]  
Cascorbi I, 1996, CANCER RES, V56, P4965
[5]  
Chen H, 2000, DRUG METAB DISPOS, V28, P315
[6]  
CHERNOGOLOV A, 2001, 12 INT C CYT P 450 L, V89, P218
[7]   STUDIES ON THE METABOLISM OF BENZO[A]PYRENE AND DOSE-DEPENDENT DIFFERENCES IN THE MUTAGENIC PROFILE OF ITS ULTIMATE CARCINOGENIC METABOLITE [J].
CONNEY, AH ;
CHANG, RL ;
JERINA, DM ;
WEI, SJC .
DRUG METABOLISM REVIEWS, 1994, 26 (1-2) :125-163
[8]   Crystallization of the N-terminal domain of human sex hormone-binding globulin, the major sex steroid carrier in blood [J].
Grishkovskaya, I ;
Sklenar, G ;
Avvakumov, GV ;
Dales, D ;
Behlke, J ;
Hammond, GL ;
Muller, YA .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 :2053-2055
[9]  
GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17
[10]  
Guengerich FP, 1998, MUTAT RES-FUND MOL M, V400, P201